Cogito: A Turnkey Solution for Rapidly Developing, Evaluating, Deploying, and Scaling Digi
This is a research study to evaluate the usability of the Cogito digital therapeutics development platform. The Cogito platform is designed to allow researchers who are seeking to embed an evidence-based behavioral therapy into a digital delivery platform to do so via a drag and drop interface with no programming skill
| Condition(s) | Substance Use Disorders (SUDs) |
|---|---|
| Status | Recruiting |
| Study type | Observational |
| Summary | This is a research study to evaluate the usability of the Cogito digital therapeutics development platform. The Cogito platform is designed to allow researchers who are seeking to embed an evidence-based behavioral therapy into a digital delivery platform to do so via a drag and drop interface with no programming skills necessary. It will provide the components for building a digital therapeutic for any health condition and population. And in this initial study, the research team plans to examine the usability of Cogito in building a digital therapeutic for substance use disorders (SUDs). |
| Who can participate | Inclusion Criteria: * At least 18 years * PhD and/or MD-level (or equivalent) scientists at academic institutions or digital health companies at the level of Post-doctoral Fellow or higher. * Training or trained in substance use disorder (SUDs) research. * Must state a specific interest in digital therapeutics for SUDs. Exclusion Criteria: * Those who do not meet inclusion criteria. |
| Ages | 18 Years |
| Sex | All |
| Accepts healthy volunteers | Yes |
| Lead sponsor | Square2 Systems, Inc. |
| Locations | Hanover, New Hampshire, United States |
| Start date | 2025-07-02 |
| NCT ID | NCT07104396 |
| Official listing | https://clinicaltrials.gov/study/NCT07104396 |